Marta Brambilla, Oncologist at the IRCCS Foundation National Cancer Institute of Milan, shared a post on X:
“Proud to present at ESMO25 our results from I3Lung about scRNAseq on PBMCs from 1L IO in NSCLC pts.
Hyperactivated mature neutrophil subset shows dysregulated pathways overlapping with those in patients with PD.
Neutrophils: not just bystanders in IO resistance?”
More posts about ESMO25 on OncoDaily.
